Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Neuroendocrine Tumors 13Meningioma 6Paraganglioma 5Neuroblastoma 5Pheochromocytoma 4Carcinoid Tumor 4von Hippel-Lindau Disease 3Medulloblastoma 3Prostatic Neoplasms 2Oncogenic osteomalacia 2Neuroectodermal Tumors, Primitive 2Multiple Endocrine Neoplasia Type 1 2Gastro-enteropancreatic neuroendocrine tumor 2Tumor Positron-Emission Tomography 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Pinealoma 1Parathyroid Neoplasms 1Pancreatic Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroma, Acoustic 1Neoplasms, Neuroepithelial 1Neoplasms 1Multiple Endocrine Neoplasia 1Metastatic Neuroendocrine Prostate Cancer 1Kidney Neoplasms 1Hypoglycemia 1Hypertension 1Hyperparathyroidism 1

Interventions

Cinacalcet 3belinostat 2Trastuzumab 2Nivolumab 2Denosumab 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1lutetium Lu 177 dotatate 1gallium Ga 68 dotatate 1fluorodopa F 18 1fluorocholine 1evocalcet 1entinostat 1acetaminophen, codeine drug combination 1Tramadol 1Tablets 1Standard of Care 1Specimen Handling 1Sodium Chloride 1Ritonavir 1Radiotherapy 1Parathyroidectomy 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Interleukin-12 Subunit p35 1Interleukin-12 1Indinavir 1Gefitinib 1Fluorouracil 1Dacarbazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Parathyroid Neoplasms × gallium Ga 68 dotatate × Clear all
NCT00001277 2022-06-07

Studies of Elevated Parathyroid Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
1,553 enrolled 8 charts
EndocrineHead & Neck

Hypercalcemia, Hyperparathyroidism, Hypoglycemia, Multiple Endocrine Neoplasia, Parathyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡